Listed

Hinge Health, Inc.

HNGENYSECIK 1673743TechnologyFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$212.8mRevenue, Q2 FY2026, three months to 2026-06-30$212.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001628280-26-054327.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 6, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$212.8mRevenue, Q2 FY2026, three months to 2026-06-30$212.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001628280-26-054327.Report this figure+53.0% on a year earlier
  • Gross margin86.4%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $183.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001628280-26-054327.Revenue: $212.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001628280-26-054327.Report this figure+16.2 pts on a year earlier
  • Operating margin19.0%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $40.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054327.Revenue: $212.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001628280-26-054327.Report this figure+436.5 pts on a year earlier
  • Net margin20.5%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $43.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054327.Revenue: $212.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001628280-26-054327.Report this figure+434.4 pts on a year earlier
  • Diluted EPS$0.52Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001628280-26-054327.Report this figureSign changed from a year earlier
  • Free cash flow$101.3mFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $101.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001628280-26-054327. Derived: 6-month figure less the 3-month figure.Capital expenditure: $123.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001628280-26-054327. Derived: 6-month figure less the 3-month figure.Report this figure+405.7% on a year earlier

Last eight quarters

Full statements
Revenue$212.8mGross margin 86.4%
Diluted EPS$0.52, Q2 FY2026
Free cash flow$101.3m, Q2 FY2026
Hinge Health, Inc., key figures for the last eight quarters
Line itemUnitperiod not labelled2024-09-30period not labelled2024-12-31period not labelled2025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$m101Revenue, period not labelled, three months to 2024-09-30$100.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001193125-25-272353.Report this figure117Revenue, period not labelled, three months to 2024-12-31$117.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001628280-26-013808. Derived: 12-month figure less the 9-month figure.Report this figure124Revenue, period not labelled, three months to 2025-03-31$123.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001628280-26-032224.Report this figure139Revenue, Q2 FY2025, three months to 2025-06-30$139.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001628280-26-054327.Report this figure154Revenue, Q3 FY2025, three months to 2025-09-30$154.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001193125-25-272353.Report this figure171Revenue, Q4 FY2025, three months to 2025-12-31$170.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001628280-26-013808. Derived: 12-month figure less the 9-month figure.Report this figure182Revenue, Q1 FY2026, three months to 2026-03-31$182.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001628280-26-032224.Report this figure213Revenue, Q2 FY2026, three months to 2026-06-30$212.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001628280-26-054327.Report this figure
Gross margin%78.8%Gross margin, period not labelled, three months to 2024-09-30. gross profit / revenueGross profit: $79.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-07, accession 0001193125-25-272353.Revenue: $100.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001193125-25-272353.Report this figure81.9%Gross margin, period not labelled, three months to 2024-12-31. gross profit / revenueGross profit: $96.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-03, accession 0001628280-26-013808. Derived: 12-month figure less the 9-month figure.Revenue: $117.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001628280-26-013808. Derived: 12-month figure less the 9-month figure.Report this figure80.9%Gross margin, period not labelled, three months to 2025-03-31. gross profit / revenueGross profit: $100.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0001628280-26-032224.Revenue: $123.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001628280-26-032224.Report this figure70.3%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $97.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001628280-26-054327.Revenue: $139.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001628280-26-054327.Report this figure81.8%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $126.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-07, accession 0001193125-25-272353.Revenue: $154.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001193125-25-272353.Report this figure84.4%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $144.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-03, accession 0001628280-26-013808. Derived: 12-month figure less the 9-month figure.Revenue: $170.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001628280-26-013808. Derived: 12-month figure less the 9-month figure.Report this figure84.6%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $154.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0001628280-26-032224.Revenue: $182.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001628280-26-032224.Report this figure86.4%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $183.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001628280-26-054327.Revenue: $212.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001628280-26-054327.Report this figure
Operating margin%(3.8%)Operating margin, period not labelled, three months to 2024-09-30. operating income / revenueOperating income: −$3.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272353.Revenue: $100.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001193125-25-272353.Report this figure17.8%Operating margin, period not labelled, three months to 2024-12-31. operating income / revenueOperating income: $20.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-03, accession 0001628280-26-013808. Derived: 12-month figure less the 9-month figure.Revenue: $117.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001628280-26-013808. Derived: 12-month figure less the 9-month figure.Report this figure10.6%Operating margin, period not labelled, three months to 2025-03-31. operating income / revenueOperating income: $13.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001628280-26-032224.Revenue: $123.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001628280-26-032224.Report this figure(417.5%)Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: −$580.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054327.Revenue: $139.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001628280-26-054327.Report this figure(4.0%)Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: −$6.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272353.Revenue: $154.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001193125-25-272353.Report this figure16.0%Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: $27.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-03, accession 0001628280-26-013808. Derived: 12-month figure less the 9-month figure.Revenue: $170.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001628280-26-013808. Derived: 12-month figure less the 9-month figure.Report this figure17.6%Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $32.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001628280-26-032224.Revenue: $182.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001628280-26-032224.Report this figure19.0%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $40.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054327.Revenue: $212.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001628280-26-054327.Report this figure
Net margin%0.3%Net margin, period not labelled, three months to 2024-09-30. net income / revenueNet income: $341.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272353.Revenue: $100.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001193125-25-272353.Report this figure23.1%Net margin, period not labelled, three months to 2024-12-31. net income / revenueNet income: $27.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-03, accession 0001628280-26-013808. Derived: 12-month figure less the 9-month figure.Revenue: $117.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001628280-26-013808. Derived: 12-month figure less the 9-month figure.Report this figure13.8%Net margin, period not labelled, three months to 2025-03-31. net income / revenueNet income: $17.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001628280-26-032224.Revenue: $123.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001628280-26-032224.Report this figure(413.8%)Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: −$575.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054327.Revenue: $139.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001628280-26-054327.Report this figure(1.2%)Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: −$1.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272353.Revenue: $154.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001193125-25-272353.Report this figure18.8%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $32.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-03, accession 0001628280-26-013808. Derived: 12-month figure less the 9-month figure.Revenue: $170.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001628280-26-013808. Derived: 12-month figure less the 9-month figure.Report this figure19.3%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $35.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001628280-26-032224.Revenue: $182.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001628280-26-032224.Report this figure20.5%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $43.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054327.Revenue: $212.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001628280-26-054327.Report this figure
Diluted EPS$ per share0.01Diluted EPS, period not labelled, three months to 2024-09-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001193125-25-272353.Report this figurenot reported (Diluted EPS not reported)1.31Diluted EPS, period not labelled, three months to 2025-03-31$1.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001628280-26-032224.Report this figure(13.10)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$13.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001628280-26-054327.Report this figure(0.02)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001193125-25-272353.Report this figurenot reported (Diluted EPS not reported)0.41Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001628280-26-032224.Report this figure0.52Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001628280-26-054327.Report this figure
Free cash flow$m28.1Free cash flow, period not labelled, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $28.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001193125-25-272353. Derived: 9-month figure less the 6-month figure.Capital expenditure: $315.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-07, accession 0001193125-25-272353. Derived: 9-month figure less the 6-month figure.Report this figure38.2Free cash flow, period not labelled, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $38.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-03, accession 0001628280-26-013808. Derived: 12-month figure less the 9-month figure.Capital expenditure: $157.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-03, accession 0001628280-26-013808. Derived: 12-month figure less the 9-month figure.Report this figure4.9Free cash flow, period not labelled, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $4.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001628280-26-032224.Capital expenditure: $51.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001628280-26-032224.Report this figure20.0Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $20.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001628280-26-054327. Derived: 6-month figure less the 3-month figure.Capital expenditure: $197.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001628280-26-054327. Derived: 6-month figure less the 3-month figure.Report this figure82.3Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $82.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001193125-25-272353. Derived: 9-month figure less the 6-month figure.Capital expenditure: $52.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-07, accession 0001193125-25-272353. Derived: 9-month figure less the 6-month figure.Report this figure63.5Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $63.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-03, accession 0001628280-26-013808. Derived: 12-month figure less the 9-month figure.Capital expenditure: $408.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-03, accession 0001628280-26-013808. Derived: 12-month figure less the 9-month figure.Report this figure43.0Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $43.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001628280-26-032224.Capital expenditure: $83.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001628280-26-032224.Report this figure101Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $101.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001628280-26-054327. Derived: 6-month figure less the 3-month figure.Capital expenditure: $123.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001628280-26-054327. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$587.9mGross margin 79.6%
Diluted EPS−$7.77, FY2025
Free cash flow$170.7m, FY2025
Hinge Health, Inc., key figures for the last five fiscal years
Line itemUnitFY2023-12-31FY2024-12-31FY20252025-12-31Shape over the periods
Revenue$m293Revenue, period not labelled, twelve months to 2023-12-31$292.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001628280-26-013808.Report this figure390Revenue, period not labelled, twelve months to 2024-12-31$390.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001628280-26-013808.Report this figure588Revenue, FY2025, twelve months to 2025-12-31$587.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001628280-26-013808.Report this figure
Gross margin%66.3%Gross margin, period not labelled, twelve months to 2023-12-31. gross profit / revenueGross profit: $194.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-03, accession 0001628280-26-013808.Revenue: $292.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001628280-26-013808.Report this figure76.8%Gross margin, period not labelled, twelve months to 2024-12-31. gross profit / revenueGross profit: $299.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-03, accession 0001628280-26-013808.Revenue: $390.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001628280-26-013808.Report this figure79.6%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $468.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-03, accession 0001628280-26-013808.Revenue: $587.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001628280-26-013808.Report this figure
Operating margin%(44.6%)Operating margin, period not labelled, twelve months to 2023-12-31. operating income / revenueOperating income: −$130.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-03, accession 0001628280-26-013808.Revenue: $292.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001628280-26-013808.Report this figure(8.2%)Operating margin, period not labelled, twelve months to 2024-12-31. operating income / revenueOperating income: −$31.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-03, accession 0001628280-26-013808.Revenue: $390.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001628280-26-013808.Report this figure(92.9%)Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: −$546.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-03, accession 0001628280-26-013808.Revenue: $587.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001628280-26-013808.Report this figure
Net margin%(36.9%)Net margin, period not labelled, twelve months to 2023-12-31. net income / revenueNet income: −$108.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-03, accession 0001628280-26-013808.Revenue: $292.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001628280-26-013808.Report this figure(3.1%)Net margin, period not labelled, twelve months to 2024-12-31. net income / revenueNet income: −$11.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-03, accession 0001628280-26-013808.Revenue: $390.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001628280-26-013808.Report this figure(89.9%)Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: −$528.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-03, accession 0001628280-26-013808.Revenue: $587.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-03, accession 0001628280-26-013808.Report this figure
Diluted EPS$ per share(8.31)Diluted EPS, period not labelled, twelve months to 2023-12-31−$8.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-03, accession 0001628280-26-013808.Report this figure(0.88)Diluted EPS, period not labelled, twelve months to 2024-12-31−$0.88 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-03, accession 0001628280-26-013808.Report this figure(7.77)Diluted EPS, FY2025, twelve months to 2025-12-31−$7.77 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-03, accession 0001628280-26-013808.Report this figure
Free cash flow$m(65.9)Free cash flow, period not labelled, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: −$63.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-03, accession 0001628280-26-013808.Capital expenditure: $2.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-03, accession 0001628280-26-013808.Report this figure48.0Free cash flow, period not labelled, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $49.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-03, accession 0001628280-26-013808.Capital expenditure: $1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-03, accession 0001628280-26-013808.Report this figure171Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $171.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-03, accession 0001628280-26-013808.Capital expenditure: $708.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-03, accession 0001628280-26-013808.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Hinge Health, Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$296.3m3,570,131Added+2,662,626
11.2 Capital Management, LLC2026-06-30$204.6m2,464,657Reduced−1,239,867
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$178.1m2,146,032Added+735,345
Deer Management Co. LLC2026-06-30$158.4m1,908,707Reduced−725,000
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$157.1m1,892,834Added+654,261
TWO SIGMA INVESTMENTS, LP2026-06-30$150.1m1,807,895Added+1,424,016
FULLER & THALER ASSET MANAGEMENT, INC.2026-06-30$142.1m1,712,507Added+57,309
MORGAN STANLEY2026-06-30$134.0m1,613,901Added+624,312
FRANKLIN RESOURCES INC2026-06-30$131.1m1,579,056Added+620,523
JANE STREET GROUP, LLC2026-06-30$117.7m1,418,317Added+861,186

Recent filings

All 288 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Hinge Health, Inc., recent filings
FiledFormWhat it isAccession number
2026-08-2120:26 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation0001628280-26-058439
2026-08-0620:14 ET10-QQuarterly reportPeriod 2026-06-300001628280-26-054327
2026-08-0420:08 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001628280-26-052558
2026-06-0920:06 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-26-041886
2026-06-0420:19 ET8-K5.07 Shareholder vote results0001628280-26-040802
2026-05-0720:33 ET10-QQuarterly reportPeriod 2026-03-310001628280-26-032224
2026-05-0520:06 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-26-030499
2026-04-1712:04 ETDEF 14AProxy statementPeriod 2026-06-030001628280-26-025602
2026-03-1720:06 ET8-K5.02 Departure or appointment of officers or directors0001628280-26-018710
2026-03-0321:11 ET10-KAnnual reportPeriod 2025-12-310001628280-26-013808

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Mar 3, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1673743
Tickers
HNGE
Exchange
NYSE
SIC code
7374 Services-Computer Processing & Data Preparation
Sector
Technology
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
<br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:45 ET. Listed shows no prices and gives no investment advice.